The Technical Analyst
Select Language :
Pliant Therapeutics Inc [PLRX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Pliant Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Pliant Therapeutics Inc is listed at the  Exchange

2.90% $14.55

America/New_York / 27 mar 2024 @ 16:00


Pliant Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 876.48 mill
EPS: -2.75
P/E: -5.29
Earnings Date: May 06, 2024
SharesOutstanding: 60.24 mill
Avg Daily Volume: 0.418 mill
RATING 2024-03-27
B
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Neutral
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/a
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -5.29 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.90x
Company: PE -5.29 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.837
(-94.25%) $-13.71
Date: 2024-03-28
Expected Trading Range (DAY)

$ 13.52 - 15.58

( +/- 7.07%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-01-23 Lefebvre Eric Buy 42 900 Common Stock
2024-01-23 Lefebvre Eric Buy 85 800 Stock Option (Right to Buy)
2024-01-23 Hull Hans Buy 31 500 Common Stock
2024-01-23 Hull Hans Buy 63 000 Stock Option (Right to Buy)
2024-01-23 Ouimette Mike Buy 31 500 Common Stock
INSIDER POWER
66.92
Last 98 transactions
Buy: 2 502 892 | Sell: 552 083

Forecast: 16:00 - $14.55

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $14.55
Forecast 2: 16:00 - $14.55
Forecast 3: 16:00 - $14.55
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $14.55 (2.90% )
Volume 0.244 mill
Avg. Vol. 0.418 mill
% of Avg. Vol 58.34 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Pliant Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Pliant Therapeutics Inc

RSI

Intraday RSI14 chart for Pliant Therapeutics Inc

Last 10 Buy & Sell Signals For PLRX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$16.20N/AActive
Profile picture for
            Pliant Therapeutics Inc

PLRX

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Last 10 Buy Signals

Date Signal @
YAR.OLMar 27 - 08:05NOK342.90
TGS.OLMar 27 - 08:05NOK118.20
AGLX.OLMar 27 - 08:05NOK30.95
GOGL.OLMar 27 - 08:09NOK136.70
EQNR.OLMar 27 - 08:08NOK286.40
MULTI.OLMar 27 - 08:05NOK148.00
DNB.OLMar 27 - 08:05NOK215.10
MOWI.OLMar 27 - 08:08NOK198.95
CADLR.OLMar 27 - 08:05NOK53.10
CLUSDMar 28 - 04:46$81.67

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.